Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02099344 · ClinicalTrials.gov registry record · Phase 4
Artegraft Versus Propaten Dialysis Grafts
A Phase 4 study, sponsored by Kaiser Permanente.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT02099344: Clinical Trial Phase 4 study, sponsored by Kaiser Permanente.
NCT02099344 is a Phase 4 study that was terminated before completion, run by Kaiser Permanente. The registered enrollment target is 1 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02099344, a Phase 4 study, was terminated before completion, sponsored by Kaiser Permanente.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Compare Artegraft and Propaten grafts for use in dialysis access to see if one performs better than the other. How long each one lasts until a complication arises or until the graft is no longer used will be compared. The study hypothesis is that the Artegraft, being an actual blood vessel, will work better than the manufactured Propaten graft.
Primary Outcome
The primary outcome will be determined by Kaplan-Meier life table analysis. Patency determination will be from access creation until the first occlusion of the graft.
Interventions
- DEVICE Artegraft
- DEVICE Propaten
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2014-04 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Why NCT02099344 stopped before completion
NCT02099344 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Artegraft is the first listed.
NCT02099344 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02099344 about?
NCT02099344 is a clinical study titled "Artegraft Versus Propaten Dialysis Grafts". Compare Artegraft and Propaten grafts for use in dialysis access to see if one performs better than the other. How long each one lasts until a complication arises or until the graft is no longer used will be compared. The study hypothesis is that the Artegraft, being an actual blood vessel, will wo...
What is the current status of trial NCT02099344?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2014-04. Estimated completion is 2014-11.
What interventions are being tested in trial NCT02099344?
The interventions under investigation include: Artegraft (DEVICE), Propaten (DEVICE).
Who is sponsoring clinical trial NCT02099344?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02099344's enrollment target sits among peer trials
1 2000th of 2000 the lowest of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia